Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riccardo Gili

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Oral Oncology|August 16, 2025
PD-L1 Expression in head and neck squamous cell carcinoma: qualitative or quantitative assessment? Is that enough or we need something more?Riccardo Gili, Patrizia Morbini, Paolo Bossi
Frontiers in Oncology|July 16, 2026
Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?Riccardo Gili, Luigi Lorini, Davide Smussi, et al.
Frontiers in Oncology|September 13, 2021
Immunotherapy for the Treatment of Cutaneous Squamous Cell CarcinomaAndrea Boutros, Federica Cecchi, Enrica Teresa Tanda, et al.
Cancers|August 10, 2024
Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future PerspectivesFrancesca Carosi, Elisabetta Broseghini, Laura Fabbri, et al.
Oral Oncology|April 15, 2025
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancerLuigi Lorini, Riccardo Gili, Carlo Resteghini, et al.
Critical Reviews in Oncology/Hematology|January 31, 2024
The treatment of advanced melanoma: Current approaches and new challengesAndrea Boutros, Elena Croce, Marco Ferrari, et al.
Critical Reviews in Oncology/Hematology|May 17, 2026
Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: from PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccinesArmando Di Bello, Riccardo Gili, Renato Falcicchia, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 5, 2024
The role of prehabilitation in HNSCC patients treated with chemoradiotherapyRiccardo Gili, Sacco Gianluca, Archetti Paolo, et al.
The Laryngoscope|December 23, 2025
Predicting Different Recurrence Risk in HNSCC Using Circulating Inflammatory and T-Cell BiomarkersRiccardo Gili, Paola Lovino Camerino, Luca Lalli, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 3, 2025
Challenges in pathological diagnosis of rare head and neck cancers: National survey and retrospective studyDaria Maria Filippini, Francesca Carosi, Giulia Querzoli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oral Oncology|August 16, 2025
PD-L1 Expression in head and neck squamous cell carcinoma: qualitative or quantitative assessment? Is that enough or we need something more?Riccardo Gili, Patrizia Morbini, Paolo Bossi
Frontiers in Oncology|July 16, 2026
Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?Riccardo Gili, Luigi Lorini, Davide Smussi, et al.
Frontiers in Oncology|September 13, 2021
Immunotherapy for the Treatment of Cutaneous Squamous Cell CarcinomaAndrea Boutros, Federica Cecchi, Enrica Teresa Tanda, et al.
Cancers|August 10, 2024
Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future PerspectivesFrancesca Carosi, Elisabetta Broseghini, Laura Fabbri, et al.
Oral Oncology|April 15, 2025
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancerLuigi Lorini, Riccardo Gili, Carlo Resteghini, et al.
Critical Reviews in Oncology/Hematology|January 31, 2024
The treatment of advanced melanoma: Current approaches and new challengesAndrea Boutros, Elena Croce, Marco Ferrari, et al.
Critical Reviews in Oncology/Hematology|May 17, 2026
Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: from PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccinesArmando Di Bello, Riccardo Gili, Renato Falcicchia, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 5, 2024
The role of prehabilitation in HNSCC patients treated with chemoradiotherapyRiccardo Gili, Sacco Gianluca, Archetti Paolo, et al.
The Laryngoscope|December 23, 2025
Predicting Different Recurrence Risk in HNSCC Using Circulating Inflammatory and T-Cell BiomarkersRiccardo Gili, Paola Lovino Camerino, Luca Lalli, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 3, 2025
Challenges in pathological diagnosis of rare head and neck cancers: National survey and retrospective studyDaria Maria Filippini, Francesca Carosi, Giulia Querzoli, et al.
Pageof 2